Tumour necrosis factor in infectious disease

John P Waters1, Jordan S Pober, John R Bradley

  • 1Department of Medicine, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK.

Insights

Tumor necrosis factor (TNF) signals through TNFR1 and TNFR2 receptors, influencing cell functions and immune responses. Understanding TNF signaling is crucial for managing infectious diseases and related inflammatory conditions.

Area of Science:

  • Immunology
  • Cell Biology
  • Molecular Medicine

Background:

  • Tumor necrosis factor (TNF) is a key cytokine involved in immune and inflammatory responses.
  • TNF exerts its effects through two receptors: TNFR1 and TNFR2.
  • Dysregulated TNF signaling contributes to tissue injury and systemic effects during infections.

Purpose of the Study:

  • To elucidate the molecular mechanisms of TNF signaling.
  • To investigate the impact of genetic diversity on TNF responses.
  • To understand the role of TNF blockade in infectious diseases.

Main Methods:

  • Analysis of TNF signaling pathways.
  • Examination of genetic variations in TNF signaling components.
  • Evaluation of therapeutic TNF blockade strategies.

Main Results:

  • TNF signaling regulates critical cellular processes including survival, proliferation, and cell death.
  • Genetic variations in TNF signaling influence disease susceptibility and outcome.
  • Therapeutic TNF blockade offers insights into TNF's role in infection.

Conclusions:

  • TNF signaling is a critical regulator of host defense and inflammation.
  • Understanding TNF's complex role is vital for developing effective treatments for infectious and inflammatory diseases.

Related Concept Videos

Cellular Injury IV: Necrosis01:16

Cellular Injury IV: Necrosis

Necrosis is a form of irreversible cell death caused by severe injury such as ischemia, toxins, or trauma. Unlike programmed cell death, it is an uncontrolled, pathological process that typically provokes inflammation in surrounding tissues.Pathophysiologic ChangesNecrosis begins when cells sustain critical damage, leading to swelling of organelles, particularly mitochondria, and rapid ATP depletion. As energy levels decline, membrane ion pumps fail, leading to calcium influx and eventually,...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab (Humira),...
Necrosis01:16

Necrosis

Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become anucleated and die, but their...
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...